arrow_back Back to App

Opioid Production Transparency: More Control Over Painkillers

This act aims to increase transparency in the production of powerful painkillers (opioids). It will provide citizens with access to information on how many opioids individual companies produce. This is intended to help better understand and control the availability of these drugs, potentially impacting the fight against the opioid crisis and public health safety.
Key points
The government will publish how many opioids each company is allowed to produce annually.
Information on the actual quantity of opioids produced by each company will be made public.
Companies' requests for opioid production quotas and their annual reports will be publicly available, unless disclosure would harm the company.
An independent report will evaluate how the government handles requests for data redaction.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3327
Sponsor: Sen. Markey, Edward J. [D-MA]
Process start date: 2021-12-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Opioid QuOTA Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_3327.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-12-07.

What are the main provisions?

Key points include:

  • The government will publish how many opioids each company is allowed to produce annually.
  • Information on the actual quantity of opioids produced by each company will be made public.
  • Companies' requests for opioid production quotas and their annual reports will be publicly available, unless disclosure would harm the company.
  • An independent report will evaluate how the government handles requests for data redaction.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Markey, Edward J. [D-MA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Courts and Law